Henry Ford Cancer Center (Site 113) — Detroit, Michigan

Henry Ford Cancer Center (Site 113) is a clinical research site located in Detroit, Michigan, United States 48186.

Crixeo Health Trust Score: 54/100 (POOR). This profile has not yet been claimed by the site owner.

Henry Ford Cancer Center (Site 113) has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Advanced Biliary Tract Cancer, Biliary Tract Cancer (BTC).

Sponsors: J-Pharma Co., Ltd..

Sponsor Feasibility Report

Trust Score: 54/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Henry Ford Cancer Center (Site 113)?

Henry Ford Cancer Center (Site 113) has a Crixeo Trust Score of 54/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Henry Ford Cancer Center (Site 113) conducted?

Henry Ford Cancer Center (Site 113) has 1 clinical trials on record, with 1 currently active. Their work covers Advanced Biliary Tract Cancer, Biliary Tract Cancer (BTC).

Is Henry Ford Cancer Center (Site 113) accredited by Crixeo Health?

Henry Ford Cancer Center (Site 113) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Henry Ford Cancer Center (Site 113)?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.